Sanofi's Pasteur unit picks W2O, Biosector 2 to support flu, meningitis work

NEW YORK: Sanofi SA's Pasteur vaccine division has awarded the accounts for its flu and meningitis businesses to W2O Group and Chandler Chicco's Biosector 2 unit, according to numerous sources. The work is collectively worth $4 million.

NEW YORK: Sanofi SA's Pasteur vaccine division has awarded the accounts for its flu and meningitis businesses to W2O Group and Chandler Chicco's Biosector 2 unit, according to numerous sources. The work is collectively worth $4 million.

An exact division of each firm's responsibilities is being determined, one source said. The contract is for work in the US only, and it consists of branded work, as well as two major consumer-facing programs with significant social media elements, sources said. The length of the contract is unknown at this time.  

W2O became eligible to bid on the account after its vaccine promotion contract with Novartis ended last fall. It is unclear if Biosector 2 has previous vaccine-related experience. The firm is known for the work it's done on Boehringer Ingelheim Pharmaceuticals' DRIVE4COPD campaign, an ongoing public-health initiative that promotes the signs of chronic obstructive pulmonary disease.

Cooney/Waters was the longtime incumbent on Sanofi's vaccine work. It decided not to rebid on the account once its most recent contract ended, closing the door on a nearly two-decade relationship.

The firm again declined to discuss why it walked away from the account. In a recent interview with PRWeek, Cooney/Waters chief strategy officer Anita Bose said only that it was time to move on.

“Two decades is a long time, but at some point relationships have to end,” Bose said.

Representatives from W2O, Bisector 2, and Sanofi Pasteur did not return several requests for comment.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in